| Literature DB >> 9801816 |
K A Berryman1, J J Edmunds, A M Bunker, S Haleen, J Bryant, K M Welch, A M Doherty.
Abstract
The development of benzothiazine-1,1-dioxide derivatives as a new structural class of potent endothelin receptor antagonists is described. Structure-activity relationships (SAR) revealed that PD164800 (1) is a potent antagonist of the ETA receptor subtype.Entities:
Mesh:
Substances:
Year: 1998 PMID: 9801816 DOI: 10.1016/s0968-0896(98)00080-7
Source DB: PubMed Journal: Bioorg Med Chem ISSN: 0968-0896 Impact factor: 3.641